HemiplegiaNCT07065916
Arm More + Camp: An Implementation Study
A study testing Modified Constraint Induced Movement Therapy in people with Hemiplegia and Cerebral Palsy Spastic Hemiplegic, run by University of Calgary at 1 site in Canada.
Trial summary
Our primary aim is to evaluate the implementation cost of a full day modified constraint induced movement therapy camp for children with hemiparesis. Participants will complete a day camp (9am to 4pm) with constraint induced movement therapy in Week 1 and bimanual therapy in Week 2. Read more about this study
- Who is it for?
- Ages 5 to 17 years
- Conditions the study is for
- Hemiplegia, Cerebral Palsy Spastic Hemiplegic, Acquired Brain Injury (Including Stroke)
- What is being tested?
- Modified Constraint Induced Movement Therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteCanada
- Study dates
- 9 Jul 2025to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 5 to 17 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Mild to moderate hemiparesis due to cerebral palsy or acquired brain injury (e.g, traumatic brain injury, stroke)
- Ability to actively extend wrist to neutral and actively flex and extend fingers (at minimum)
- Attend school full-time
- Able to participate in group activities
- Written consent
Who cannot join
- Severe hemiparesis due to cerebral palsy or acquired brain injury
- No wrist movement on the hemiplegic hand.
- Unable to concentrate for periods of 60-90minutes
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Arm More + Camp: An Implementation Study of a Modified Constraint Induced Movement Therapy Camp for Children With Hemiparesis
Our primary aim is to evaluate the implementation cost of a full day modified constraint induced movement therapy camp for children with hemiparesis.
Participants will complete a day camp (9am to 4pm) with constraint induced movement therapy in Week 1 and bimanual therapy in Week 2.
- Being tested
- Modified Constraint Induced Movement Therapy
- Keywords
- Cerebral palsy, Constraint induced movement therapy, Bimanual therapy, Hemiplegia
- Medical subject headings
- Hemiplegia, Brain Injuries, Cerebral Palsy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Modified Constraint Induced Movement TherapyBehavioural
Constraint Induced Movement Therapy and Bimanual Therapy
| Study group | Role | What they receive |
|---|---|---|
| Modified Constraint Induced Movement Therapy | Other | Constraint Induced Movement Therapy and Bimanual Therapy Receives: Behavioral: Modified Constraint Induced Movement Therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Implementation Cost
Implementation cost covers all resources necessary, including personnel, time, space, and supplies.
Measured: From enrolment to the end of outcome data collection at 3 weeks
Secondary outcomes (1)
Canadian Occupational Performance Measure
Measured: Baseline and the end of treatment at 2 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jul 2025
- Study start9 Jul 2025
- Primary completion31 Aug 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HemiplegiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Calgary
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Adam Kirton, University of Calgary
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07065916
- Sponsor's protocol ID
- REB25-0524
- Status last verified
- Jul 2025
- First submitted
- 25 Jun 2025
- Last updated
- 1 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Arm More + Camp: An Implementation Study of a Modified Constraint Induced Movement Therapy Camp for Children With Hemiparesis
- ClinicalTrials.gov ID
- NCT07065916
- Acronym / sponsor ID
- REB25-0524
- Keywords
- Cerebral palsy, Constraint induced movement therapy, Bimanual therapy, Hemiplegia
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- University of CalgaryUniversity, hospital or other
- Study start
- 9 Jul 2025 (actual)
- Primary completion
- 31 Aug 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 15 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Our primary aim is to evaluate the implementation cost of a full day modified constraint induced movement therapy camp for children with hemiparesis.
Participants will complete a day camp (9am to 4pm) with constraint induced movement therapy in Week 1 and bimanual therapy in Week 2.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Modified Constraint Induced Movement Therapy | Other | Behavioral: Modified Constraint Induced Movement TherapyConstraint Induced Movement Therapy and Bimanual Therapy |
Who may qualify
- Ages
- 5 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (5 listed)
- Mild to moderate hemiparesis due to cerebral palsy or acquired brain injury (e.g, traumatic brain injury, stroke)
- Ability to actively extend wrist to neutral and actively flex and extend fingers (at minimum)
- Attend school full-time
- Able to participate in group activities
- Written consent
Key exclusion criteria (3 listed)
- Severe hemiparesis due to cerebral palsy or acquired brain injury
- No wrist movement on the hemiplegic hand.
- Unable to concentrate for periods of 60-90minutes
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Modified Constraint Induced Movement TherapyConstraint Induced Movement Therapy and Bimanual Therapy | Behavioural | Modified Constraint Induced Movement Therapy |
Primary outcome
Implementation Cost
Time frame: From enrolment to the end of outcome data collection at 3 weeks
Implementation cost covers all resources necessary, including personnel, time, space, and supplies.
1 secondary outcome
Canadian Occupational Performance Measure
Time frame: Baseline and the end of treatment at 2 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2026.
Related trials for Hemiplegia
RecruitingObservational study
Functional Benefits of Multisite Upper Limb Surgery in Children With Unilateral Cerebral Palsy (RETRO-CHIRc)
Cerebral Palsy, Hemiplegia
Not yet recruitingObservational study
Post-Stroke Apraxia, Motor Function, Balance, and Gait
Stroke, Ideomotor Apraxia
Not yet recruitingObservational study
Ideomotor Apraxia and Robotic Gait Rehabilitation Outcomes After Stroke
Stroke, Ideomotor Apraxia
Active, not recruiting
Visual and Auditory Electromyography Biofeedback Among Stroke Patients
Stroke, Hemiplegia
Enrolling by invitationObservational study
Evaluation of a Voice-Activated Call Light System for Clients With Limited Upper-Extremity Mobility
Spinal Cord Injury (=3 Years), Traumatic Brain Injury (TBI) Patients
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Modified Constraint Induced Movement Therapy in people with Hemiplegia and Cerebral Palsy Spastic Hemiplegic, run by University of Calgary at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Implementation Cost (time frame: From enrolment to the end of outcome data collection at 3 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026; AzTrials last refreshed its copy on 27 Oct 2026.